CFDE Data Portal | Search DNMT3B

	Label	Description
	DNMT3B Gene (Entity type)	ENSG00000088305 - DNA methyltransferase 3 beta
	GSE172458 polycomb DNMT3B knockdown Cisplatin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE172458 polycomb DNMT3B knockdown Cisplatin 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	DNMT3B associations Collection (Entity type)	Associations for DNMT3B_associations
	DNMT3B Up Gene Set (Entity type)	A Gene Set from LINCS
	DNMT3B Down Gene Set (Entity type)	A Gene Set from LINCS
	DNMT3B associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	PAFAH1B3 Gene (Entity type)	ENSG00000079462 - platelet activating factor acetylhydrolase 1b catalytic subunit 3
	GSE216273,GSE216292 14 V 6 PALBOCICLIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE150244 TRIM8 knockout 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS

DNMT3B

ENSG00000088305 - DNA methyltransferase 3 beta

GSE172458 polycomb DNMT3B knockdown Cisplatin 0 v 1 human up

A Gene Set from LINCS

GSE172458 polycomb DNMT3B knockdown Cisplatin 0 v 1 human dn

A Gene Set from LINCS

DNMT3B associations

Associations for DNMT3B_associations

DNMT3B Up

A Gene Set from LINCS

DNMT3B Down

A Gene Set from LINCS

DNMT3B associations.tsv

A file from IDG as part of the Harmonizome project

PAFAH1B3

ENSG00000079462 - platelet activating factor acetylhydrolase 1b catalytic subunit 3

GSE216273,GSE216292 14 V 6 PALBOCICLIB HUMAN DN

A Gene Set from LINCS

GSE150244 TRIM8 knockout 3 v 0 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.